Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Clinical Development
Biologics
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending T
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Clinical Development
Biologics
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Vancomycin
Biotech
Crestone’s antibiotic beats vancomycin at treating C. diff
Crestone's med stopped C. diff’s notorious comebacks: Just 4% of patients who received it had their infections return, compared to 23% for vancomycin.
Darren Incorvaia
Sep 5, 2024 3:11pm
Summit turns to partnerships for failed C. difficile med
Mar 18, 2022 11:18am
Fighting superbugs with ‘supercharged’ antibiotics
Jan 8, 2018 9:40am